Source-grounded facts extracted from Regenerative Medical Technology Group Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Regenerative Medical Technology Group Inc. entered into Equity Financing Agreement with GHS valued at up to $10,000,000 (effective 2023-12-08).
“On December 8, 2023, we entered into an Equity Financing Agreement (the “Financing Agreement”) and Registration Rights Agreement with GHS.”
Regenerative Medical Technology Group Inc. dismissed L J Soldinger Associates, LLC as its auditor.
“On September 22, 2023, we dismissed L J Soldinger Associates, LLC (the "Former Accountant") as our independent registered public accounting firm and, on September 22, 2023, we engaged Victor Mokuolu, CPA PLLC (the "New Accountant") as our independent registered public accounting firm.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.